Glycated albumin and risk of death and hospitalizations in diabetic dialysis patients

Clinical Journal of the American Society of Nephrology

Volumn 6, Issue 7, 2011, Pages 1635-1643

  Freedman, Barry I ^a   Andries, Lilian ^a   Shihabi, Zak K ^a   Rocco, Michael V ^a   Byers, Joyce R ^a   Cardona, Cesar Y ^a   Pickard, Michael A ^b   Henderson, David L ^b   Sadler, Margie V ^b   Courchene, Leah M ^b   Jordan, Jean R ^c   Balderston, Somer S ^c   Graham, Angie D ^c   Mauck, Vicki L ^c   Russell, Gregory B ^a   Bleyer, Anthony J ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b Meridian Laboratory Corporation   (United States)

^c Meridian Laboratory Corporation ^*

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; ASPARTATE AMINOTRANSFERASE; BROMCRESOL PURPLE; CREATININE; FERRITIN; GLUCOSE; GLYCOSYLATED ALBUMIN; HEMOGLOBIN; INSULIN; PHOSPHORUS; SERUM ALBUMIN;

ADULT; AGED; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BODY MASS; CARDIOVASCULAR DISEASE; COMORBIDITY; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DIABETIC PATIENT; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEMODIALYSIS; HEMODIALYSIS PATIENT; HEMOGLOBIN BLOOD LEVEL; HOSPITALIZATION; HUMAN; INFECTIOUS COMPLICATION; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY FAILURE; KIDNEY GRAFT; MAJOR CLINICAL STUDY; MALE; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PERIPHERAL VASCULAR DISEASE; PHOSPHATE BLOOD LEVEL; SURVIVAL;

AFRICAN AMERICANS; AGED; BIOLOGICAL MARKERS; BLOOD GLUCOSE; CHI-SQUARE DISTRIBUTION; DIABETIC NEPHROPATHIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HOSPITALIZATION; HUMANS; KIDNEY FAILURE, CHRONIC; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; NORTH CAROLINA; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RENAL DIALYSIS; RISK ASSESSMENT; RISK FACTORS; SERUM ALBUMIN; TIME FACTORS;

EID: 79960311683     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.11491210     Document Type: Article

References (20)

1. Inaba M, Okuno S, Kumeda Y, Yamada S, Imanishi Y, Tabata T, Okamura M, Okada S, Yamakawa T, Ishimura E, Nishizawa Y: Glycated albumin is a better glycemic indicator than glycated hemoglobin values in hemodialysis patients with diabetes: Effect of anemia and erythropoietin injection. J Am Soc Nephrol 18: 896-903, 2007
2. Peacock TP, Shihabi ZK, Bleyer AJ, Dolbare EL, Byers JR, Knovich MA, Calles-Escandon J, Russell GB, Freedman BI: Comparison of glycated albumin and hemoglobin A(1c) levels in diabetic subjects on hemodialysis. Kidney Int 73: 1062-1068, 2008
3. Nagayama H, Inaba M, Okabe R, Emoto M, Ishimura E, Okazaki S, Nishizawa Y: Glycated albumin as an improved indicator of glycemic control in hemodialysis patients with type 2 diabetes based on fasting plasma glucose and oral glucose tolerance test. Biomed Pharmacother 63: 236-240, 2009
4. Freedman BI, Shenoy RN, Planer JA, Clay KD, Shihabi ZK, Burkart JM, Cardona CY, Andries L, Peacock TP, Sabio H, Byers JR, Russell GB, Bleyer AJ: Comparison of glycated albumin and hemoglobin A1C concentrations in diabetic subjects on peritoneal and hemodialysis. Perit Dial Int 30: 72-79, 2010
5. Freedman BI, Shihabi ZK, Andries L, Cardona CY, Peacock TP, Byers JR, Russell GB, Stratta RJ, Bleyer AJ: Relationship between assays of glycemia in diabetic subjects with advanced chronic kidney disease. Am J Nephrol 31: 375-379, 2010
6. Viljoen M, de Oliveira AA, Milne FJ: Physical properties of the red blood cells in chronic renal failure. Nephron 59: 271-278, 1991
7. Kalantar-Zadeh K, Kopple JD, Regidor DL, Jing J, Shinaberger CS, Aronovitz J, McAllister CJ, Whellan D, Sharma K: A1C and survival in maintenance hemodialysis patients. Diabetes Care 30: 1049-1055, 2007
8. Williams ME, Lacson E Jr, Teng M, Ofsthun N, Lazarus JM: Hemodialyzed type I and type II diabetic patients in the US: Characteristics, glycemic control, and survival. Kidney Int 70: 1503-1509, 2006
9. Stratton IM, Adler AI, Neil HA, Matthews DR, Manley SE, Cull CA, Hadden D, Turner RC, Holman RR: Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): Prospective observational study. BMJ 321: 405-412, 2000
10. Adler AI, Stevens RJ, Manley SE, Bilous RW, Cull CA, Holman RR: Development and progression of nephropathy in type 2 diabetes: The United Kingdom Prospective Diabetes Study (UKPDS 64). Kidney Int 63: 225-232, 2003
11. The American Diabetes Association (ADA) has been actively involved in the development and dissemination of diabetes care standards, guidelines, and related documents for many years. Diabetes Care 32[Suppl 1]: S1-S2, 2009
12. Fukuoka K, Nakao K, Morimoto H, Nakao A, Takatori Y, Arimoto K, Taki M, Wada J, Makino H: Glycated albumin levels predict long-term survival in diabetic patients undergoing haemodialysis. Nephrology 13: 278-283, 2008
13. Williams ME, Lacson E Jr, Teng M, Hakim RM, Lazarus JM: Extremes of glycemic control (HbA1c) increase hospitalization risk in diabetic hemodialysis patients in the USA. Am J Nephrol 29: 54-61, 2009
14. Shurraw S, Majumdar SR, Thadhani R, Wiebe N, Tonelli M: Glycemic control and the risk of death in 1,484 patients receiving maintenance hemodialysis. Am J Kidney Dis 55: 875-884, 2010
15. Mittman N, Desiraju B, Meyer KB, Chattopadhyay J, Avram MM: Treatment of secondary hyperparathyroidism in ESRD: A 2-year, single-center crossover study. Kidney Int 78: S33-S36, 2010
16. Kovesdy CP, Park JC, Kalantar-Zadeh K: Glycemic control and burnt-out diabetes in ESRD. Semin Dial 23: 148-156, 2010
17. Tahara Y, Shima K: Kinetics of HbA1c, glycated albumin, and fructosamine and analysis of their weight functions against preceding plasma glucose level. Diabetes Care 18: 440-447, 1995
18. Gerstein HC, Swedberg K, Carlsson J, McMuarry JJ, Michelson EL, Olofssom B: The hemoglobin A1c level as a progressive risk factor for cardiovascular death, hospitalization for heart failure, or death in patients with chronic heart failure. Arch Intern Med 168: 1699-1704, 2008
19. Traynor JP, Thomson PC, Simpson K, Ayansina DT, Prescott GJ, Mactier RA: Comparison of patient survival in non-diabetic transplant-listed patients initially treated with haemodialysis or peritoneal dialysis. Nephrol Dial Transplant 26: 245-252, 2010
20. Isakova T, Gutierrez OM, Chang Y, Shah A, Tamez H, Smith K, Thadhani R, Wolf M: Phosphorus binders and survival on hemodialysis. J Am Soc Nephrol 20: 388-396, 2009